Skip to main content

PPN World · Archive

Reserved for subscribers

This release sits in the PPN World archive. Subscribers read the full wire as it lands — 80+ newswires, 190+ countries, searchable back through the archive, with alerts on the subjects they track.

  • · Every release, the moment it crosses — not a daily digest
  • · Search and filter the full archive, not the last 24 hours
  • · Instant alerts on saved searches

PPN World — real-time press release intelligence.

Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S. · GlobeNewswire — Public Companies · PPN World